Literature DB >> 21273974

Ovarian cancer: a bright future.

Robert M Wenham.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21273974     DOI： 10.1177/107327481101800101

Source DB:  PubMed          Journal:  Cancer Control        ISSN： 1073-2748            Impact factor:   3.302


× No keyword cloud information.
  2 in total

1.  RHPN2 Promotes Malignant Cell Behaviours in Ovarian Cancer by Activating STAT3 Signalling.

Authors:  Fengsheng Yu; Pingping Qiao; Guangjie Yin; Yewu Sun; Xiao Yu; Xin Sun; Yijing Chu; Yankui Wang
Journal:  Onco Targets Ther       Date:  2020-11-10       Impact factor: 4.147

2.  Antiangiogenic Therapy with Human Apolipoprotein(a) Kringle V and Paclitaxel in a Human Ovarian Cancer Mouse Model.

Authors:  Hyun-Kyung Yu; Ho-Jeong Lee; Seok-Joong Yun; Sun-Joo Lee; Robert R Langley; Yeup Yoon; Lee S H Yi; Duk-Soo Bae; Jang-Seong Kim; Sun Jin Kim
Journal:  Transl Oncol       Date:  2014-06-17       Impact factor: 4.243
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.